Position in RNA
as of Mar 31, 2026
· filed May 21, 2026
Position Value
$397,062
New position
Shares Held
29,698
first reported quarter
Ownership
0.174%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Groupe la Francaise holds $42,995,507 across 10 Biotechnology names. RNA ranks #6 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACLX |
Arcellx, Inc.
|
151,046 | $17,343,101 | |
| 2 | FOLD |
AMICUS THERAPEUTICS, INC.
|
939,655 | $13,587,411 | |
| 3 | TERN |
Terns Pharmaceuticals, Inc.
|
118,449 | $6,244,631 | |
| 4 | DAWN |
Day One Biopharmaceuticals, Inc.
|
179,495 | $3,848,372 | |
| 5 | KZR |
Kezar Life Sciences, Inc.
|
80,400 | $596,568 | |
| 6 | RNA |
Atrium Therapeutics, Inc.
This page
|
29,698 | $397,062 | |
| 7 | BNTX |
BioNTech SE
|
4,200 | $373,296 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
442 | $341,506 |
All Filings in RNA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $397,062 | 29,698 | Shares | Defined | 2026-05-21 | |
| No filing history on record for this holder in this stock. | ||||||